BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26995965)

  • 1. [TUMOR SUPPRESSOR p63 REGULATES EXPRESSION OF UBIQUITIN LIGASE Pirh2].
    Daks AA; Petukhov AV; Shuvalov OY; Vasilieva EA; Melino G; Barlev NA; Fedorova OA
    Tsitologiia; 2015; 57(12):876-9. PubMed ID: 26995965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pirh2, a ubiquitin E3 ligase, inhibits p73 transcriptional activity by promoting its ubiquitination.
    Wu H; Zeinab RA; Flores ER; Leng RP
    Mol Cancer Res; 2011 Dec; 9(12):1780-90. PubMed ID: 21994467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.
    Jung YS; Qian Y; Chen X
    J Biol Chem; 2011 Oct; 286(41):35388-35395. PubMed ID: 21852228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
    Li Y; Zhou Z; Chen C
    Cell Death Differ; 2008 Dec; 15(12):1941-51. PubMed ID: 18806757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic suppresses cell survival via Pirh2-mediated proteasomal degradation of ΔNp63 protein.
    Yan W; Chen X; Zhang Y; Zhang J; Jung YS; Chen X
    J Biol Chem; 2013 Feb; 288(5):2907-13. PubMed ID: 23271742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itch/AIP4 associates with and promotes p63 protein degradation.
    Rossi M; De Simone M; Pollice A; Santoro R; La Mantia G; Guerrini L; Calabrò V
    Cell Cycle; 2006 Aug; 5(16):1816-22. PubMed ID: 16861923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pirh2 E3 ubiquitin ligase modulates keratinocyte differentiation through p63.
    Jung YS; Qian Y; Yan W; Chen X
    J Invest Dermatol; 2013 May; 133(5):1178-87. PubMed ID: 23235527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
    Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
    Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitination-dependent degradation of p73 by the mitochondrial E3 ubiquitin ligase Hades.
    Min B; Ryu J; Chi SW; Yi GS
    Biochem Biophys Res Commun; 2015 Nov; 467(2):316-21. PubMed ID: 26435500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53.
    Zheng G; Ning J; Yang YC
    Biochem Biophys Res Commun; 2007 Dec; 364(2):344-50. PubMed ID: 17950244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide reactivates proteasome-dependent degradation of mutant p53 protein in cancer cells in part via enhanced expression of Pirh2 E3 ligase.
    Yan W; Jung YS; Zhang Y; Chen X
    PLoS One; 2014; 9(8):e103497. PubMed ID: 25116336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The homeodomain transcription factor Hoxa2 interacts with and promotes the proteasomal degradation of the E3 ubiquitin protein ligase RCHY1.
    Bergiers I; Bridoux L; Nguyen N; Twizere JC; Rezsöhazy R
    PLoS One; 2013; 8(11):e80387. PubMed ID: 24244684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System.
    Armstrong SR; Wu H; Wang B; Abuetabh Y; Sergi C; Leng RP
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27929429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of p63 by Itch.
    Melino G; Knight RA; Cesareni G
    Cell Cycle; 2006 Aug; 5(16):1735-9. PubMed ID: 16931910
    [No Abstract]   [Full Text] [Related]  

  • 16. Pirh2, an E3 ligase, regulates the AIP4-p73 regulatory pathway by modulating AIP4 expression and ubiquitination.
    Abou Zeinab R; Wu HH; Abuetabh Y; Leng S; Sergi C; Eisenstat DD; Leng RP
    Carcinogenesis; 2021 Apr; 42(4):650-662. PubMed ID: 33569599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ubiquitin-protein ligase Itch regulates p73 stability.
    Rossi M; De Laurenzi V; Munarriz E; Green DR; Liu YC; Vousden KH; Cesareni G; Melino G
    EMBO J; 2005 Feb; 24(4):836-48. PubMed ID: 15678106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity.
    Chen D; Ming L; Zou F; Peng Y; Van Houten B; Yu J; Zhang L
    Oncotarget; 2014 Sep; 5(18):8107-22. PubMed ID: 25237903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p53 paddy wagon: COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest.
    Corcoran CA; Huang Y; Sheikh MS
    Cancer Biol Ther; 2004 Aug; 3(8):721-5. PubMed ID: 15280670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin ligase COP1 is a critical negative regulator of p53.
    Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
    Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.